Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
March 12, 2024
Location Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease?
Megan Stefkovich, Paul M Titchenell
Cellular and Molecular Gastroenterology and Hepatology
|
February 15, 2022
Curing Fatty Liver with Oxysterols?
Kahealani Uehara, Paul M Titchenell
Cellular and Molecular Gastroenterology and Hepatology
|
February 12, 2019
Resolving the Paradox of Hepatic Insulin Resistance
Dominic Santoleri, Paul M Titchenell
Diabetes
|
May 25, 2013
Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy
Paul M Titchenell, David A Antonetti
Cellular and Molecular Gastroenterology and Hepatology
|
May 24, 2023
Liver Fat - Gone, but Not Forgotten?
Paul M Titchenell, Joseph A Baur
Cellular and Molecular Gastroenterology and Hepatology
|
March 30, 2020
Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
Anna E Garcia Whitlock, Paul M Titchenell
Trends in Endocrinology and Metabolism: TEM
|
April 19, 2017
Unraveling the Regulation of Hepatic Metabolism by Insulin
Paul M Titchenell, Mitchell A Lazar, Morris J Birnbaum
Endocrinology
|
March 18, 2022
Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice
Jaimarie Sostre-Colón, Matthew J Gavin, Dominic Santoleri, et al.
Comprehensive Physiology
|
June 26, 2023
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E Garcia Whitlock, et al.
Nature Communications
|
May 13, 2015
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Paul M Titchenell, Qingwei Chu, Bobby R Monks, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Cellular and Molecular Gastroenterology and Hepatology
|
March 12, 2024
Location Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease?
Megan Stefkovich, Paul M Titchenell
Cellular and Molecular Gastroenterology and Hepatology
|
February 15, 2022
Curing Fatty Liver with Oxysterols?
Kahealani Uehara, Paul M Titchenell
Cellular and Molecular Gastroenterology and Hepatology
|
February 12, 2019
Resolving the Paradox of Hepatic Insulin Resistance
Dominic Santoleri, Paul M Titchenell
Diabetes
|
May 25, 2013
Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy
Paul M Titchenell, David A Antonetti
Cellular and Molecular Gastroenterology and Hepatology
|
May 24, 2023
Liver Fat - Gone, but Not Forgotten?
Paul M Titchenell, Joseph A Baur
Cellular and Molecular Gastroenterology and Hepatology
|
March 30, 2020
Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
Anna E Garcia Whitlock, Paul M Titchenell
Trends in Endocrinology and Metabolism: TEM
|
April 19, 2017
Unraveling the Regulation of Hepatic Metabolism by Insulin
Paul M Titchenell, Mitchell A Lazar, Morris J Birnbaum
Endocrinology
|
March 18, 2022
Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice
Jaimarie Sostre-Colón, Matthew J Gavin, Dominic Santoleri, et al.
Comprehensive Physiology
|
June 26, 2023
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E Garcia Whitlock, et al.
Nature Communications
|
May 13, 2015
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Paul M Titchenell, Qingwei Chu, Bobby R Monks, et al.
Page
of 6